Evidence map›Paper›PMID 41155327›Full record

ArticleInternational journal of molecular sciences2025

Emulsified Homo (Ciprofloxacin) Polymer Nanoparticles for Antibacterial Applications.

Faeez Mahzamani, Edward Turos

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Faeez MahzamaniDepartment of Chemistry, University of South Florida, 4202 E. Fowler Avenue, Tampa, FL 33620, USA.
Edward TurosDepartment of Chemistry, University of South Florida, 4202 E. Fowler Avenue, Tampa, FL 33620, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report for the first time a method for forming polyacrylate nanoparticles using N-acryloylciprofloxacin as a sole monomer for emulsion polymerization. The procedure involves a free radical-induced emulsion polymerization of N-acryloylciprofloxacin monomer to produce a stable aqueous emulsion comprising uniformly sized polyacrylate nanoparticles. Dynamic light scattering analysis of the emulsions showed a single population of nanoparticles having an average diameter of 970 nm and average surface charge of -63 mV, indicative of the high stability of the emulsion and significantly enhance lipophilicity of the polymeric matrix of the nanoparticle. Antibacterial testing of the emulsions against the Gram-positive microbe

Indexed as

Anti-Bacterial AgentsCiprofloxacinNanoparticlesPolymersAcrylic ResinsEmulsionsEscherichia coliHEK293 CellsHumansMicrobial Sensitivity TestsParticle SizeStaphylococcus aureusAcrylic ResinsAnti-Bacterial AgentsCiprofloxacinEmulsionsPolymersantibacterialciprofloxacinemulsion polymerizationnanoparticlesStaphylococcus aureus

Identifiers

PMID41155327
PMCPMC12563473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.